You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Screen for hepatitis B virus in all cancer patients starting systemic treatment. Find out more about hepatitis B virus screening and management.

luspatercept

Pronunciation: lus PAT er sept
Other Name(s): Reblozyl®
Appearance: colourless to slightly yellow liquid

Drug Formulary information is intended for use by healthcare professionals. It is not intended to be medical advice. Some of the information, including information about funding for cancer drugs, does not apply to all patients. Cancer treatment plans are unique to each patient. If you are a patient, please speak with your healthcare team to understand how this information applies to you.

Patient Info Sheet

Jul 2025

What it is used for

For treating anemia (low red blood cells) that may happen with a certain type of blood cancer (myelodysplastic syndromes or MDS).



You might also be interested in